AVITA Medical, Inc.RCELNASDAQ
Loading
Gross Profit Growth Recovery in ProgressRecovering
Percentile Rank49
3Y CAGR-24.2%
5Y CAGR-3.0%
Year-over-Year Change
Year-over-year gross profit growth rate
3Y CAGR
-24.2%/yr
vs -59.4%/yr prior
5Y CAGR
-3.0%/yr
Recent deceleration
Acceleration
+35.1pp
Accelerating
Percentile
P49
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 3.14% |
| Q3 2025 | -7.18% |
| Q2 2025 | -4.67% |
| Q1 2025 | -2.76% |
| Q4 2024 | -1.41% |
| Q3 2024 | 25.01% |
| Q2 2024 | 36.42% |
| Q1 2024 | -22.65% |
| Q4 2023 | 7.52% |
| Q3 2023 | 20.77% |
| Q2 2023 | 7.50% |
| Q1 2023 | 9.56% |
| Q4 2022 | 7.22% |
| Q3 2022 | 8.82% |
| Q2 2022 | 20.62% |
| Q1 2022 | -5.85% |
| Q4 2021 | 3.15% |
| Q3 2021 | -28.11% |
| Q2 2021 | 24.66% |
| Q1 2021 | 54.58% |
| Q4 2020 | 3.66% |
| Q3 2020 | 37.56% |
| Q2 2020 | -7.40% |
| Q1 2020 | 34.40% |
| Q4 2019 | -38.10% |
| Q3 2019 | 134.78% |
| Q2 2019 | 0.00% |
| Q1 2019 | 279.31% |
| Q4 2018 | -2.54% |
| Q3 2018 | 22025.47% |
| Q2 2018 | -98.46% |
| Q1 2018 | -1.16% |
| Q4 2017 | -0.50% |
| Q3 2017 | -8.26% |
| Q2 2017 | 0.60% |
| Q1 2017 | 37.56% |
| Q4 2016 | -5.73% |
| Q3 2016 | 27.55% |
| Q2 2016 | -3.07% |
| Q1 2016 | -31.42% |